- Amid FDA chaos, approval of a rare disease drug gets delayed — again statnews.com
- FDA delays PDUFA date for small biotech, raising questions about impact of agency cuts Endpoints News
- Barth Syndrome Foundation Calls for Urgent FDA Action Following Elamipretide Delay The Joplin Globe
- US FDA Miss On Stealth’s Elamipretide Boosts Signal Of Broader Delays Due To Staff Cuts insights.citeline.com
- Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application PR Newswire